178 related articles for article (PubMed ID: 9723358)
1. Cyclosporine-based steroid-free therapy in pediatric heart transplantation: long-term results.
Livi U; Caforio AL; Gambino A; Tursi V; Milanesi O; Stellin G; Angelini A; Casarotto D
Transplant Proc; 1998 Aug; 30(5):1975-6. PubMed ID: 9723358
[No Abstract] [Full Text] [Related]
2. Twelve years of cyclosporine in pediatric heart transplantation: what is the future?
Parisi F; Abbattista AD; Squitieri C; Vinciguerra G; La Vigna G; Di Donato R; Catena G
Transplant Proc; 1998 Aug; 30(5):1967-8. PubMed ID: 9723355
[No Abstract] [Full Text] [Related]
3. Ten year experience in orthotopic heart transplantation: single center result.
Aziz T; el-Gamel A; Krysiak P; Rahman A; Campbell C; Yonan N; Deiraniya A
Transplant Proc; 1998 Aug; 30(5):1915-6. PubMed ID: 9723331
[No Abstract] [Full Text] [Related]
4. Sole immunosuppressive maintenance with cyclosporine A after heart transplantation.
Koerner MM; Tenderich G; Mannebach H; zu Knyphausen E; Koertke H; Kleesiek K; Gleichmann U; Meyer H; Koerfer R
Transplant Proc; 1996 Dec; 28(6):3119-21. PubMed ID: 8962209
[No Abstract] [Full Text] [Related]
5. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience.
Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO
Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449
[No Abstract] [Full Text] [Related]
6. Multicenter evaluation of immunosuppressive regimens in heart transplantation. The Collaborative Transplant Study.
Opelz G
Transplant Proc; 1997; 29(1-2):617-9. PubMed ID: 9123156
[No Abstract] [Full Text] [Related]
7. Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
Walker RE; McCrindle BW; Coles JG; West LJ
Transplant Proc; 1998 Jun; 30(4):1116-7. PubMed ID: 9636452
[No Abstract] [Full Text] [Related]
8. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
[No Abstract] [Full Text] [Related]
9. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
Marcus N; Khaghani A; Burke M; Yacoub M; Banner N
Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
[No Abstract] [Full Text] [Related]
10. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center.
Lavee J; Bar-Zohar D; Har-Zahav Y; Freimark D; Casif Y; Shinfeld A; Smolinsky AK
Transplant Proc; 2000 Jun; 32(4):737-9. PubMed ID: 10856565
[No Abstract] [Full Text] [Related]
11. Risk factors for early mortality, acute rejection, and factors affecting first-year survival after heart transplantation.
Aziz T; el-Gamel A; Krysiak P; Rahman A; Campbell C; Yonan N; Deiraniya A
Transplant Proc; 1998 Aug; 30(5):1912-4. PubMed ID: 9723330
[No Abstract] [Full Text] [Related]
12. Long-term results of kidney grafts surviving beyond the first year: comparison of cyclosporine-based regimens with the azathioprine and steroid regimen.
Rizzolo M; Puggia R; Maresca MC; Calconi G; Vianello A
Transplant Proc; 1998 Aug; 30(5):1751-2. PubMed ID: 9723266
[No Abstract] [Full Text] [Related]
13. Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.
Gómez-Sánchez MA; Delgado JF; Escribano P; Santos M; Sotelo T; Gil R; Hernández-Afonso J; Ortuño B; Romero F; Sáenz de la Calzada C; Rodriguez JE; Rufilanchas JJ
Transplant Proc; 1998 Aug; 30(5):1671-2. PubMed ID: 9723237
[No Abstract] [Full Text] [Related]
14. Effects of cyclosporine A monotherapy on the incidence of rejection and infection episodes in heart transplant patients.
Seydoux C; Stumpe F; Hurni M; Ruchat P; Fischer A; Mueller X; von Segesser L; Goy JJ
Transplant Proc; 1998 Dec; 30(8):4037-43. PubMed ID: 9865288
[No Abstract] [Full Text] [Related]
15. Impact of cyclosporine dose on long-term outcome after heart transplantation.
Valantine H; Hunt S; Gamberg P; Miller J; Luikart H
Transplant Proc; 1994 Oct; 26(5):2710-2. PubMed ID: 7940848
[No Abstract] [Full Text] [Related]
16. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK
Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168
[No Abstract] [Full Text] [Related]
17. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H
Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
[No Abstract] [Full Text] [Related]
18. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
[No Abstract] [Full Text] [Related]
19. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
[No Abstract] [Full Text] [Related]
20. Effect of acute rejection episodes on long-term renal graft survival.
Berczi C; Asztalos L; Kincses Z; Löcsey L; Balázs G
Transplant Proc; 1998 Aug; 30(5):1775. PubMed ID: 9723277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
